tiprankstipranks
CytomX Therapeutics Inc (DE:6C1)
FRANKFURT:6C1
Holding DE:6C1?
Track your performance easily

CytomX Therapeutics (6C1) Cash flow

3 Followers

CytomX Therapeutics Cash Flow

DE:6C1's free cash flow for Q3 2024 was $-20.75M. For the 2024 fiscal year, DE:6C1's free cash flow was decreased by $55.65M and operating cash flow was $-20.73M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -88.29M$ -56.03M$ -110.79M$ -119.03M$ 5.26M$ -140.48M
Investing Cash Flow
$ 97.43M$ -150.67M$ 98.26M$ 22.49M$ -18.72M$ 79.70M
Financing Cash Flow
$ 5.52M$ 30.23M$ 648.00K$ 110.21M$ 16.89M$ 1.63M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 140.96M$ 18.09M$ 194.57M$ 206.45M$ 192.78M$ 189.34M
Income Tax Paid Supplemental Data
-----$ 13.06M
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 4.84M--$ 107.71M$ 11.29M-
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -88.78M$ -56.88M$ -112.53M$ -120.64M$ 2.95M$ -143.98M
Domestic Sales
------
Foreign Sales
------
Currency in USD

CytomX Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis